SAT-1 activators encompass a diverse assembly of chemical entities specifically engineered or identified to enhance the functional activity of Sphingosine Acyltransferase 1 (SAT-1), an enzyme pivotal in the biosynthesis of ceramides through the acylation of sphingosine. These activators are not unified by a common chemical structure but are instead characterized by their ability to augment the catalytic efficiency of SAT-1. Their mode of action involves the direct increase in the enzyme's substrate affinity or the allosteric modification of the enzyme's conformation, leading to an accelerated formation of ceramide. Ceramides, in turn, are central to the sphingolipid metabolism and play a crucial role in the structural integrity of cell membranes, signal transduction, and cell differentiation processes. SAT-1 activators exert their effects by either facilitating the binding of sphingosine to the active site of SAT-1 or by inducing conformational changes that stabilize the enzyme in an active form, thereby promoting the synthesis of ceramides.
The specificity of SAT-1 activators lies in their selective interaction with the enzyme, which distinguishes them from broad-spectrum compounds that affect multiple targets within sphingolipid metabolism. This selectivity is of paramount importance because it ensures that the activation of SAT-1 is achieved without inadvertently modulating the activity of other enzymes involved in lipid metabolism. Through the precise targeting of SAT-1, these activators enable an increase in ceramide production, which in turn can regulate various cellular processes linked to the sphingolipid signaling cascade. The chemical compounds that act as SAT-1 activators are instrumental in dissecting the biological pathways mediated by ceramides and offer valuable tools for probing the complex regulatory networks that govern cell fate and function. Their utilization provides insights into the intricate mechanisms of sphingolipid metabolism and the role of SAT-1 within these pathways, highlighting their significance in fundamental cellular activities.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn activates PKA. Activated PKA can phosphorylate SAT-1, enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor that prevents cAMP degradation, thereby sustaining PKA activation and SAT-1 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits PDE4, leading to increased cAMP and downstream PKA activation, which can subsequently enhance SAT-1 function. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc acts as a cofactor for many enzymes and may stabilize the structure of SAT-1, which can lead to its functional enhancement. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to activate protein kinases which may lead to the phosphorylation and activation of SAT-1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins that modulate cellular pathways potentially leading to the activation of SAT-1. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride acts as a nonspecific phosphatase inhibitor, which may prevent dephosphorylation and thus maintain SAT-1 in an active state. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which may reduce negative regulation of SAT-1, leading to its activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which can lead to the activation of various proteins, potentially including SAT-1 by indirect pathways. | ||||||